What are the Potential Side Effects of Drinking Jeera and Methi Water?
Do you know that excess Jeera (Cumin) or methi (Fenugreek) water can pose side effects? It is hard to believe that these culinary herbs can also have ...
Lupin Receives Approval for Meloxicam Capsules
Tuesday June 2, 2020 at 11:46 amMumbai, Baltimore, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg and 10 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Vivlodex® Capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc. The product would be manufactured at Lupin’s Aurangabad facility, India, and is expected to be launched shortly.
Meloxicam Capsules, 5 mg and 10 mg, are indicated for management of osteoarthritis (OA) pain.
Meloxicam Capsules (RLD: Vivlodex®) had an annual sales of approximately USD 14 million in the U.S. (IQVIA MAT March 2020).
